Related Experiment Video
Updated: May 2, 2026

A Novel Procedure for Evaluating the Reinforcing Properties of Tastants in Laboratory Rats: Operant Intraoral Self-administration
Published on: February 6, 2014
Causal association between glucagon-like peptide-1 receptor agonists and mental disorders: insight from genetic and
Chenhao Ouyang1, Xiaoyue Zhang2, Minghai Zhang3
1Department of Anesthesiology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, China.
Background:
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), recognized for hypoglycemic and weight reduction efficacy, have been debated regarding potential association with mental disorders. This study sought to elucidate causal relationship between GLP-1RAs and mental disorders.
Method:
Two-sample Mendelian randomization, Linkage Disequilibrium Score Regression (LDSC) and Bayesian co-localization were conducted to assess causal associations between Glucagon-like peptide-1 receptor (GLP-1R) and seven mental disorders: anxiety, bipolar affective disorders, chronic depression, depression, eating disorders, suicide and schizophrenia. A meta-analysis of clinical studies was conducted between GLP-RAs use and mental health.
Results:
LDSC revealed no genetic associations between GLP-1R and six mental disorders (Eating disorders were excluded from LDSC due to negative SNP-based heritability). GLP-1R were not causally related to mental disorders: anxiety (OR = 0.870, PFDR = 0.250), bipolar affective disorders (OR = 0.931, PFDR = 1.00), chronic depression (OR = 1.012, PFDR = 0. 878), depression (OR = 0.985, PFDR = 1.00), eating disorders (OR = 0.885, PFDR = 1.00), suicide (OR = 1.040, PFDR = 0.915), schizophrenia (OR = 1.064, PFDR = 1.00). These findings were validated using eQTLGen Consortium or Psychiatric Genomics Consortium (all PFDR > 0.900) and corroborated by Bayesian co-localization. The meta-analysis revealed no significant difference between the GLP-1 RAs exposure group and the control group in suicidal ideation or behavior (OR = 0.92, POR = 0.67), anxiety (OR = 1.03, POR = 0.93), depressive symptoms (SMD = -0.25, PSMD = 0.39), but showed a significant difference in eating disorders (SMD = -0.71, PSMD = 0.006).
Conclusion:
GLP-1R showed no genetic evidence linking anxiety, bipolar affective disorders, chronic depression, depression, eating disorders, suicide, and schizophrenia. The pooled results of real-world evidence showed consistent results.
More Related Videos
08:13Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
Published on: May 18, 2020
05:15Author Spotlight: Accessible M&M-Based Mouse Model for Investigating Binge Eating Disorder - Insights into Eating Behaviors, Anxiety, and Neural Mechanisms
Published on: January 10, 2025
Related Concept Videos
Blind Procedures
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Taste Buds and Receptors
Drug Abuse and Addiction: Pharmacological Phenomena
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...